Q4 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript
© -
Good afternoon and welcome, everybody, to this 2023 results (technical difficulty) meeting, which will start in a moment.
This is Javier López-Belmonte, ROVI's Deputy Chairman and Chief Financial Officer. Please let me introduce ROVI's attendees today. Juan López-Belmonte, Chairman and CEO; Marta Campos, Head of Finance; Beatriz de Zavala, Investor Relations; Victoria Lopez-Belmonte, Investor Relations; and myself. At the end of the presentation, a question-and-answer session will start. If you want to ask any questions during the presentation, please do not hesitate to send them through the question button on the platform.
Thank you for your presence here today. And let's now start with the presentation. I give Mr. Juan López-Belmonte the floor.
© -
Thank you, Javier, and welcome to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |